Wave aims for monthly dosing with RNA editing treatment for AATD

Paul Bolno, Wave Life Sciences CEO May 19, 2026 11:19 AM EDT R&D Wave aims for month­ly dos­ing with RNA edit­ing treat­ment for AATD Lei Lei Wu News Reporter Wave Life Sci­ences re­port­ed an up­dat­ed cut of da­ta from its ear­ly-stage study of an RNA edit­ing treat­ment for al­pha-1 an­tit­rypsin … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER